Like Adaptive Software LLC

closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
closed 12/18/2020 via BusinessWire

Kyruus, acquired HealthSparq

synopsis: Kyruus has acquired HealthSparq, a trailblazing healthcare guidance and transparency technology company serving health plans. HealthSparq will become part of Kyruus, accelerating a groundbreaking platform to connect payer and provider organizations and enabling people to find and schedule with the right providers seamlessly across access channels.
buyer: Kyruus
Kyruus delivers leading provider search and scheduling solutions that help health systems match patients with the right providers. The Kyruus ProviderMatch suite of solutions enables a modern and consistent patient experience while optimizing provider utilization. "
target parent: Cambia Health Solutions, Inc.
target: HealthSparq
HealthSparq is a healthcare guidance and transparency technology company serving health plans. The company's HealthSparq One solution is a SaaS platform that offers provider search, cost estimation, reviews, appointment scheduling, and more to empower people to make smarter health care choices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/27/2011 via GlobeNewswire

Verisk Analytics, Inc., acquired Bloodhound Technologies, Inc.

synopsis: Verisk Analytics, Inc., a leading source of information about risk, announced it has closed its acquisition of Bloodhound Technologies, Inc., a premier provider of real-time pre-adjudication claims editing for healthcare payers. Bloodhound's payment integrity solution ConVergence Point is offered through a SaaS delivery model.
buyer: Verisk Analytics, Inc. (NasdaqGS:VRSK:$2,889.60)
Verisk Analytics is a leading provider of information about risk to professionals in insurance, healthcare, mortgage, government, and risk management. Verisk Analytics helps customers protect people, property, and financial assets. "
target: Bloodhound Technologies, Inc.
Bloodhound Technologies is the leading claims editing service and analytics provider that offers a fully transparent, customizable, real-time service for all participants in the claims revenue cycle.
price ($mm)
$75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BusinessWire

MultiPlan, Inc., acquired HSTechnology Solutions, Inc.

synopsis: MultiPlan Corporation has acquired HST, an innovative healthcare technology company that enables value-based health benefit plan designs. Adding HST’s technology-enabled services to MultiPlan’s offerings will further extend the company’s capabilities and enhance its mission to improve affordability and fairness in the healthcare system.
buyer parent: Hellman & Friedman LLC
buyer: MultiPlan, Inc. (:$928.82)
MultiPlan, Inc. is the industry's most comprehensive provider of healthcare cost management solutions. The company provides a single gateway to a host of primary, complementary and out-of-network strategies for managing the financial risks associated with healthcare claims. "
target: HSTechnology Solutions, Inc.
HST is an innovative healthcare technology company that enables value-based health benefit plan designs. HST’s platform uses data analytics and tools to engage members and providers on both the front and back end of healthcare, enhancing collaboration and improving the management of medical costs.
price ($mm)
$140
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2017 via BusinessWire

Vestar Capital Partners, acquired Quest Analytics, L.L.C.

synopsis: Vestar Capital Partners, a private equity firm, announced that it has acquired Quest Analytics, L.L.C. Quest Analytics is a leader in health plan provider network management software and services. Quest Analytics provides critically important software and cloud-based solutions for both health plans and the regulators who monitor their performance.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target: Quest Analytics, L.L.C.
Quest Analytics is an independent solutions company, built without ownership ties to any health plan, providing commercial software development and consulting services for hundreds of health plans, consultants, and government agencies in the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/27/2021 via PR Newswire

Cody Consulting Group, Inc., acquired Madena, Ltd.

synopsis: CODY, a Tampa, Florida-based healthcare technology and consulting firm, has acquired Madena, a recognized consulting and software leader with an emphasis on enrollment, billing and reconciliation that is best known for its enrollment and reconciliation software, Synchronicity™.
buyer: Cody Consulting Group, Inc.
CODY is a Tampa, Florida-based healthcare technology and consulting firm. CODY® works with more than 60 government-funded, commercial and Affordable Care Act (ACA) health plans to help improve regulatory compliance, manage plan benefit data, and streamline member and provider communications. "
target: Madena, Ltd.
Founded in 2012, Madena offers a comprehensive suite of proprietary software, business process outsourcing and consulting services to help Medicare Advantage and Prescription Drug plans enhance revenue and support the enrollment and reconciliation process.
price ($mm)
$7.30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2020 via PR Newswire

Novo Benefits, LLC, acquired Allay Inc.

synopsis: Novo Benefits, a leader in self-funded insurance, has acquired Allay, a technology platform that makes it easy for benefit consultants to model and quote self-funded health plans. The platform will be renamed Novo Connection to better integrate with Novo's existing portfolio of products.
buyer: Novo Benefits, LLC
Novo Benefits builds custom self-funded health insurance programs to help its customers maximize benefit offerings while containing costs. Novo Benefits champions industry innovators who are challenging the industry to bring change to healthcare. "
target: Allay Inc.
Allay is a technology platform that makes it easy for benefit consultants to model and quote self-funded health plans. The company's online platform lets consultants model self-funding strategies, understand a group’s risk, customize plan designs and plan components, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via BNC Analysis

Wipro, Ltd., acquired HealthPlan Services

synopsis: Wipro Limited, a leading global information technology, consulting and business process services company, announced that it has acquired HealthPlan Services. HealthPlan has grown to become the leading independent technology and Business Process as a Service (BPaaS) provider in the U.S. Health Insurance market.
buyer: Wipro, Ltd. (BSE:507685:$8,354.10)
Wipro Ltd. is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of "Business through Technology.” "
target parent: Water Street Healthcare Partners
target: HealthPlan Services
HealthPlan Services delivers a best-in-class administrative technology platform and consumer engagement services to Payers and agents across the public exchange, private exchange and off-exchange individual markets.
price ($mm)
$460
rev ($mm)
$223
EBITDA ($mm)
EV / rev
2.1x
EV / EBITDA
closed 5/11/2015 via BusinessWire

Towers Watson, acquired Acclaris, Inc

synopsis: Towers Watson, a global professional services company, announced that it has acquired Acclaris, a provider of software-as-a-service (SaaS)-based technology and services for consumer-driven health care and reimbursement accounts, including health savings accounts (HSAs), health reimbursement arrangements (HRAs) and other consumer directed accounts.
buyer: Towers Watson (TW:$3,644.95)
Towers Watson is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. Towers Watson offers solutions in the areas of employee benefits, talent management, rewards, and risk and capital management. "
target parent: Staley Capital
target: Acclaris, Inc
Acclaris provides the services and technology that health plans, benefit consultants and financial institutions rely on to deliver health care and reimbursement accounts to a growing market.
price ($mm)
$140
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via Company Press Release

ABRY Partners, LLC, acquired Centauri Health Solutions

synopsis: Abry Partners has acquired a majority stake in Centauri Health Solutions, Inc., an innovative provider of healthcare technology and services. Centauri exists to create custom solutions for health plans and hospitals. The flexible Centauri software platform was built with clients in mind.
buyer: ABRY Partners, LLC
Abry is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $82.0 billion of leveraged transactions and other private equity or preferred equity placements. "
target: Centauri Health Solutions
Centauri Health Solutions, Inc. is an innovative provider of healthcare technology and services. Centauri exists to create custom solutions for health plans and hospitals. The flexible Centauri software platform was built with clients in mind.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2020 via BNC Analysis

IngenioRx, acquired Zipdrug, Inc.

synopsis: Anthem’s pharmacy benefit manager, IngenioRx, has acquired Zipdrug, a healthcare company that facilitates in-home drug delivery and helps health plans track medication adherence. The acquisition gives IngenioRx access to Zipdrug’s services and the ability to sell them to health plans as part of its offering or as a standalone pharmacy service.
buyer parent: Anthem, Inc.
buyer: IngenioRx
IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. The company offers a whole health approach that helps drive better outcomes and lowers member, employer, and plan costs. "
target: Zipdrug, Inc.
ZipDrug is a data-driven healthcare company bringing better outcomes to patients and payers and increased revenue and reputation to partner pharmacies. ZipDrug simplifies the pharmacy experience by connecting patients to pharmacies and delivering lower cost prescriptions directly to their door.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/21/2020 via PR Newswire

HealthVerity, acquired Curisium

synopsis: HealthVerity, the leader in privacy-protected data exchange, announced that it has acquired Curisium, an innovator in cloud-based drug rebate processing and contract performance management.
buyer: HealthVerity
HealthVerity has emerged as a leader and key partner to nearly 75% of top pharmaceutical manufacturers and payers, having fundamentally changed the way that key healthcare organizations secure, exchange and synthesize HIPAA-protected information at scale. "
target: Curisium
Curisium is an innovator in cloud-based drug rebate processing and contract performance management. Curisium's cutting-edge platform enables payers, pharmaceutical manufacturers and providers to enter into innovative contracting arrangements in a secure, efficient, scalable, data-driven way.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/15/2017 via PR Newswire

Traffk, acquired Capsci Health

synopsis: Traffk, the Los Angeles based insurance technology company, is excited to announce the acquisition of Portland, Ore.-based Capsci Health. Capsci Health's HIPAA compliant, mobile technology platform personalizes health plan members' benefits, allowing them direct access to their plan's benefits, ID cards, preferred providers and telemedicine.
buyer: Traffk
Traffk helps insurance-related companies manage, use and expand their data to improve underwriting accuracy, manage risk, realize market growth and retention and create data-optimized solutions and product offerings. Their SaaS platform is powered by insurance experts, data scientists, and AI. "
target: Capsci Health
Capsci Health is a medical IT company providing mobile solutions that dramatically improve access to care. Capsci Health's HIPAA compliant, mobile technology platform personalizes health plan members' benefits, allowing them direct access to their plan's benefits, ID cards, and preferred providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/8/2019 via BusinessWire

Kemberton Healthcare, acquired Advanced Patient Advocacy, LLC

synopsis: Kemberton, a leader in specialized revenue cycle management (SRCM) services, announced the acquisition of Advanced Patient Advocacy (APA), a Columbia, Maryland-based SRCM provider for hospitals and health systems throughout the U.S.
buyer: Kemberton Healthcare
Kemberton is a leading provider of tech-enabled revenue cycle management services to hospitals for complex claims. They specialize in the management and collection of workers’ compensation, veteran administration and the resolution of insurance denials for hospitals and physician practice groups. "
target: Advanced Patient Advocacy, LLC
Advanced Patient Advocacy, LLC is a privately owned company that provides a comprehensive suite of enrollment services to healthcare organizations to assist patients in navigating and connecting to payer solutions which include Medicaid, Workers Compensation, Motor Vehicle, Disability and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

Lightyear Capital LLC, purchased FIS Healthcare Benefit Solutions Business from Fidelity National Information Services Inc.

synopsis: Lightyear Capital LLC announced that an affiliate of Lightyear Fund III, L.P. completed its acquisition of the Healthcare Benefit Solutions business from FIS™. The business provides benefits administration SaaS, multi-purse debit cards and transaction processing solutions for consumer directed healthcare accounts.
buyer: Lightyear Capital LLC
Lightyear Capital is a leading private equity firm making primarily control investments in North America based, middle-market financial services companies. Lightyear has managed approximately $3 billion of committed capital with investments across the financial services spectrum. "
seller parent: Fidelity National Financial, Inc.
seller: Fidelity National Information Services Inc. (FIS:$9,241.00)
FIS Healthcare Benefit Solutions Business provides benefits administration SaaS, multi-purse debit cards and transaction processing solutions for consumer directed healthcare accounts.
price ($mm)
$335
rev ($mm)
$120
EBITDA ($mm)
$34
EV / rev
2.8x
EV / EBITDA
9.9x
announced 7/2/2010 via BusinessWire

HMS, will acquire Allied Management Group

synopsis: HMS announced it has signed a definitive agreement to acquire privately-held Allied Management Group (AMG-SIU), a leading provider of fraud, waste, and abuse prevention and detection solutions for healthcare payors, in an all-cash transaction.
buyer: HMS (HMSY:$642.75)
HMS is the nation’s leader in coordination of benefits and program integrity services for payors of healthcare services. "
target: Allied Management Group
Established in 1972, AMG-SIU provides audit and consulting services to both government and commercial healthcare payors. The company has developed a proprietary forensic claim editing system to analyze claim data for patterns of fraud, waste, and abuse.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2009 via Company Press Release

Providence Equity Partners Inc., acquired ikaSystems Corporation

synopsis: ikaSystems Corporation and Providence Equity Partners LLC, announced that Providence has invested in ikaSystems. ikaSystems, a provider of enterprise-level Web-based technologies for the healthcare payer market, will use the proceeds to fund future growth.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target: ikaSystems Corporation
ikaSystems is healthcare payers’ premier provider of enterprise-level Web-based technologies for commercial, Medicare and Medicaid lines of business. ikaEnterprise, the company’s flagship product, automates all key processes in the payer business cycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/11/2012 via Company Press Release

HealthEdge, acquired Click4Care Inc.

synopsis: HealthEdge®, provider of the only modern, enterprise-class software platform for healthcare payors, announced that it has acquired Click4Care, a software company that provides industry-leading care management and utilization management solutions for healthcare payors.
buyer parent: Psilos Group
buyer: HealthEdge
HealthEdge® provides the only modern, enterprise-class software platform for healthcare payors. Using the patented HealthRules® software suite, health plans, health insurance companies, and other payors can respond to new business opportunities and market changes in hours. "
target: Click4Care Inc.
Click4Care is a software company that provides industry-leading care management and utilization management solutions for healthcare payors. Click4Care is an award-winning software company providing workflow, content and communication to and amongst everyone in the care equation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/23/2017 via BusinessWire

One Call Care Management, acquired High Line Health

synopsis: One Call Care Management, a leading provider of workers’ compensation care management services, announced it has completed the acquisition of High Line Health, a progressive value-based analytics and data visualization platform.
buyer: One Call Care Management
One Call is the nation’s leading provider of specialized solutions to the workers’ compensation industry. One Call’s solutions enable faster, more efficient and more cost-effective claims resolution with a focus on injured workers’ needs across the continuum of care. "
target: High Line Health
High Line Health provides health insurers, Accountable Care Organizations and large employer groups with web-based applications that facilitate the measurement and tracking of healthcare quality and efficiency.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,614.03)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
closed 5/14/2015 via PR Newswire

Decision Resources Group, acquired Healthcare Business Insights

synopsis: Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., announced that it has acquired Healthcare Business Insights (HBI), a trusted provider of best practice research, training and services to more than 1,400 hospitals across the U.S. HBI's member-centric Academies enable hospitals to understand how to address critical issues.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Healthcare Business Insights
Healthcare Business Insights (HBI) is a leading provider of in-depth research and thoughtful insights across the core business functions found in hospitals and health systems nationwide. HBI's membership programs include Revenue Cycle, IT, Supply Chain and Cost & Quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2015 via PR Newswire

Decision Resources Group, acquired Activate Networks

synopsis: Decision Resources Group, a leading research and advisory company focused on high-value healthcare data, insights and analytics, announced that it acquired Activate Networks. Their analytics platform and suite of SaaS software applications enable healthcare/life sciences companies to unlock the commercial value of their customer networks.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Activate Networks
Activate Networks, Inc. is the leading provider of network analytics for healthcare/life sciences companies. Their analytics platform and suite of SaaS software applications enable healthcare/life sciences companies to unlock the commercial value of their customer networks.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 4/17/2012 via BusinessWire

Decision Resources Group, acquired Pinsonault Associates, LLC.

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Pinsonault, a leading provider in offering managed markets-specific business and training solutions to the pharmaceutical and biotech industries.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Pinsonault Associates, LLC.
Pinsonault is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2011 via BusinessWire

Decision Resources Group, acquired PharmaStrat, Inc.

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, has acquired PharmaStrat, the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry. "
target: PharmaStrat, Inc.
PharmaStrat is the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. It delivers strategic perspectives and market insight solutions that proactively address challenges and opportunity.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2008 via PR Newswire

Decision Resources, Inc., acquired Manhattan Research, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Manhattan Research, Inc.
Manhattan Research is a healthcare market research and advisory services firm, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via

Decision Resources, Inc., purchased Life Sciences business from Wood Mackenzie

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that it plans to acquire Wood Mackenzie's Life Sciences business.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
seller: Wood Mackenzie
Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. Our market proposition is based on our ability to provide forward- looking insight that enables our clients to make better business decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2006 via PR Newswire

Decision Resources, Inc., acquired Millennium Research Group

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced today that it acquired Millennium Research Group, the global authority on medical technology market intelligence.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Millennium Research Group
Millennium Research Group is a leading provider of strategic information to the healthcare sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the Company provides its clients with the benefits of its specialized industry expertise through published reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2005 via BusinessWire

HCPro, acquired HealthLeaders, Inc.

synopsis: HCPro, Inc. today announced it has significantly broadened its healthcare publishing lines by acquiring HealthLeaders Media from Decision Resources, Inc. The acquisition includes the monthly HealthLeaders magazine, several general healthcare business email publications, live events and a state-specific healthcare business news service.
buyer parent: The Riverside Company
buyer: HCPro
HCPro is a leading provider of integrated information, education, training, and consulting products and services in the vital areas of healthcare regulation and compliance. The company's mission is to meet the specialized informational, advisory, and educational needs of the healthcare industry. "
target parent: Boston Ventures Management, Inc.
target: HealthLeaders, Inc.
HealthLeaders is a leading multi-platform media company dedicated to meeting the business information needs of healthcare executives and professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/9/2021 via Company Press Release

Telstra Health, will acquire MedicalDirector

synopsis: Telstra announced that Telstra Health has entered into a binding agreement to acquire leading GP clinical and practice management software company MedicalDirector. MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is Australia's largest ehealth company. Telstra Health provides technology solutions that help improve the quality, efficiency and security of health services. They offer products and solutions for electronic medical records, telehealth, back office, medication management and more. "
target parent: Affinity Equity Partners
target: MedicalDirector
MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, and clinical content.
price ($mm)
$257
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,614.03)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2016 via BNC Analysis

Affinity Equity Partners, acquired MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners has acquired Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$1,614.03)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Adaptive Software LLC


read more

Adaptive Software LLC

HealthSparq

Bloodhound Technologies, Inc.

HSTechnology Solutions, Inc.

Quest Analytics, L.L.C.

Madena, Ltd.

Allay Inc.

HealthPlan Services

Acclaris, Inc

Centauri Health Solutions

Zipdrug, Inc.

Curisium

YouScript, Inc.

Capsci Health

Advanced Patient Advocacy, LLC

Fidelity National Information Services Inc.

Allied Management Group

ikaSystems Corporation

Click4Care Inc.

High Line Health

read more

Adaptive Software LLC

read more

Decision Resources Group

Context Matters

Adaptive Software LLC

Healthcare Business Insights

Activate Networks

Relay Technology Management

Abacus International

Decision Resources Group

Pinsonault Associates, LLC.

PharmaStrat, Inc.

BioTrends Research Group, Inc.

Manhattan Research, Inc.

Fingertip Formulary

Arlington Medical Resources Inc.

Wood Mackenzie

Decision Resources, Inc.

Millennium Research Group

HealthLeaders, Inc.

Decision Resources, Inc.

read more

MedicalDirector

Decision Resources Group

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Abacus International

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Pharmaspectra

SpringerProtocols

ERT

NHiS Ltd

ERT

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

Context Matters

Geography
Matching Companies
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc
Scrypt builds secure cloud-based workflow management and collaboration tools for regulated industries. They help businesses operating in regulated industries improve document workflow and regain valuable time while protecting business-critical information.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.86)
EBIT ($mm)
($0.92)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: HAXS
 
 
 
 
 
 
 
 
Healthaxis, Inc.
Healthaxis, Inc.
HealthAxis Group is simultaneously the most experienced and modern SaaS-based supplier of benefit platform systems. The comprehensive suite offered by HealthAxis helps organizations address compliance, increase administrative efficiency, lower cost, and improve quality.
year
2007
rev ($mm)
$16.03
EBITDA ($mm)
$0.27
EBIT ($mm)
($0.86)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: CTRX
 
 
 
 
 
 
 
 
Catamaran Corporation
Catamaran Corporation
Catamaran Corporation helps organizations and the communities they serve take control of prescription drug costs. Managing more than 400 million prescriptions each year on behalf of 35 million members, Catamaran's solutions improve patient care and empower individuals to take charge of their health.
year
2014
rev ($mm)
$21,581.89
EBITDA ($mm)
$845.68
EBIT ($mm)
$569.00
Net Income ($mm)
$317.29
Employees
4000
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch